Endpoint
Preterm birth incidence
CAT:outcome/preterm-birth-incidencereported in risk ratio or odds ratio1 finding from 1 compound
What moved it
How to read these marks1 finding · 1 compound · 1 null · by grade
| Compound | Direction | Findings | Best grade |
|---|---|---|---|
| magnesium(2+) | no effect | 1 | Grade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence. |
Every finding here is a null result.
Measured, no effect detected
1 finding
magnesium(2+) — no detected effect on
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“No differences in the incidence of preterm birth or perinatal mortality were seen when magnesium maintenance therapy was compared with placebo or no treatment; or alternative therapies (ritodrine or terbutaline).”
Quoted verbatim from Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.. - Study
- meta-analysis
- Population
- women with threatened preterm labour previously arrested by initial tocolysis, given magnesium maintenance therapy versus placebo/no treatment or versus alternative tocolytics (ritodrine or terbutaline) (Cochrane review of 4 RCTs, 422 women)
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.2013PMID:23728634Permalink
How it is measured
Incidence of preterm birth, delivery before 37 completed weeks of gestation, ascertained from the delivery record. The population is recorded with each finding, because symptomatic women after arrested threatened preterm labour and an unselected pregnant population do not share a baseline rate.
Sources cited
1 paper
- Subject
- preterm birth incidence
- Findings
- 1
- Papers
- 1